RecruitingPHASE1, PHASE2NCT06574581
ADSCs Therapy in Patients With CTD-ILD
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- China Medical University Hospital
- Intervention
- ADSC01(biological)
- Enrollment
- 16 enrolled
- Eligibility
- 20-80 years · All sexes
- Timeline
- 2024 – 2026
Study locations (1)
- China Medical University Hospital, Taichung, Taiwan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06574581 on ClinicalTrials.govOther trials for Secondary interstitial lung disease in childhood and adulthood associated with a connective tissue disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2, PHASE3NCT06674148A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Qifangfeixian Granules in the Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)Huilan Zhang
- ACTIVE NOT RECRUITINGNCT05503030Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) PatientsBoehringer Ingelheim